[{"NetIncomeLoss_1_Q3_USD":-197310000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":57190000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":450953000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-346656000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":311000000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q3_USD":411000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":446500000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":7495000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-4995000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":78812000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q3_USD":5000000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":415000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":61554000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":54810000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":56879000.0,"InterestPaidNet_3_Q3_USD":12188000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":83977000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":8226000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":2000.0,"CommonStockSharesIssued_0_Q3_shares":63318888.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":96488000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":18000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":-26000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":8899000.0,"InterestExpenseDebtExcludingAmortization_1_Q3_USD":3047000.0,"InterestExpenseDebtExcludingAmortization_3_Q3_USD":9141000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":5116000.0,"TreasuryStockValue_0_Q3_USD":41207000.0,"TreasuryStockShares_0_Q3_shares":391403.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":65235000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":199822000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":63099000.0,"OtherNoncashIncomeExpense_3_Q3_USD":4119000.0,"OperatingLeaseExpense_1_Q3_USD":16000.0,"AssetsCurrent_0_Q3_USD":671217000.0,"FinanceLeaseInterestExpense_1_Q3_USD":1041000.0,"ConvertibleLongTermNotesPayable_0_Q3_USD":321679000.0,"MarketableSecuritiesCurrent_0_Q3_USD":169860000.0,"OperatingLeaseLiability_0_Q3_USD":3868000.0,"InvestmentIncomeNet_1_Q3_USD":140000.0,"InvestmentIncomeNet_3_Q3_USD":872000.0,"BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_1_Q3_USD":-4300000.0,"Revenues_1_Q3_USD":157024000.0,"Revenues_3_Q3_USD":195939000.0,"CommonStockValue_0_Q3_USD":633000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":80135000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":60540000.0,"ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_3_Q3_USD":199822000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":3565000.0,"FinanceLeasePrincipalPayments_1_Q3_USD":65424000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":65424000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":33000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":415000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":6729000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":3900000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":952000.0,"InterestPayableCurrent_0_Q3_USD":2031000.0,"BusinessAcquisitionsProFormaRevenue_3_Q3_USD":195939000.0,"BusinessAcquisitionsProFormaRevenue_1_Q3_USD":157024000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-26000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":18000.0,"FinanceLeaseLiability_0_Q3_USD":118959000.0,"Liabilities_0_Q3_USD":637758000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":334171000.0,"OtherAssetsNoncurrent_0_Q3_USD":8294000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":500000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-189110000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-233182000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":62623000.0,"DeferredRevenueNoncurrent_0_Q3_USD":2500000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q3_USD":127858000.0,"CostsAndExpenses_1_Q3_USD":350966000.0,"CostsAndExpenses_3_Q3_USD":429805000.0,"UnamortizedDebtIssuanceExpense_0_Q3_USD":3321000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":580152000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":169860000.0,"Assets_0_Q3_USD":944020000.0,"ShareBasedCompensation_3_Q3_USD":77602000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"AccountsPayableCurrent_0_Q3_USD":15097000.0,"DeferredRevenueCurrent_0_Q3_USD":81814000.0,"LiabilitiesCurrent_0_Q3_USD":239218000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":3900000.0,"PaymentsToAcquireProductiveAssets_3_Q3_USD":12610000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_1_Q3_USD":-196590000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_3_Q3_USD":-242411000.0,"InterestExpense_3_Q3_USD":11266000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":86027000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":7495000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":65705000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":77602000.0,"Goodwill_0_Q3_USD":126932000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.066,"LongTermDebtPercentageBearingFixedInterestRate_0_Q3_pure":0.0375,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":20000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":8226000.0,"InterestExpense_1_Q3_USD":4460000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":401736000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":83851000.0,"NetIncomeLoss_3_Q3_USD":-240695000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":131834000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":43300000.0,"ReceivablesNetCurrent_0_Q3_USD":12355000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":6189000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":5332000.0,"AdditionalPaidInCapital_0_Q3_USD":1848644000.0,"ShortTermLeaseCost_1_Q3_USD":19390000.0,"SecurityDeposit_0_Q3_USD":400000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q3_USD":725000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_3_Q3_USD":5870000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.065,"FinanceLeaseRightOfUseAssetAmortization_3_Q3_USD":187193000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":5332000.0,"InterestExpenseDebt_1_Q3_USD":3403000.0,"InterestExpenseDebt_3_Q3_USD":10209000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":35708000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":8200000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":294087000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":7513000.0,"AmortizationOfFinancingCosts_1_Q3_USD":356000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":65705000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":77602000.0,"PreferredStockSharesAuthorized_0_Q3_shares":2000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":944020000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":12061000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":164300000.0,"OperatingIncomeLoss_1_Q3_USD":-193942000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":187200000.0,"OperatingIncomeLoss_3_Q3_USD":-233866000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":78788000.0,"DebtInstrumentFaceAmount_0_Q3_USD":325000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":164204000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":32000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":447070000.0,"CommonStockSharesAuthorized_0_Q3_shares":600000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":104000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":65424000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":67154000.0,"AmortizationOfFinancingCosts_3_Q3_USD":1068000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":266330000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":415000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"CommonStockSharesOutstanding_0_Q3_shares":62927485.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":319556000.0,"LeaseCost_1_Q3_USD":85871000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1696635000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q3_USD":415000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":169842000.0,"StockholdersEquity_0_Q3_USD":106440000.0,"GoodwillAcquiredDuringPeriod_3_Q3_USD":70662000.0,"OtherLiabilitiesCurrent_0_Q3_USD":5604000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":55860000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":11262000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-3.21,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-4.39,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":415000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":345828000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201110"}]